Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker CRBP
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Cormorant Asset Management, LP | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 425,000 | $4.10 | $1.7M Sale | Form 4 ↗ |
| Sep 14, 2026 | Yong Ben Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,000 | $7.84 | $15.7K Sale | Form 4 ↗ |
| Aug 11, 2026 | Nishant C. Saxena Chief Business Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Buy | 2,600 | $9.63 | $25.0K Buy | Form 4 ↗ |
| Aug 7, 2026 | Yuval Cohen Chief Executive Officer, Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 17,000 | $10.08 | $171.4K Sale | Form 4 ↗ |
| Aug 7, 2026 | Sean F. Moran Chief Financial Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 12,000 | $10.08 | $121.0K Sale | Form 4 ↗ |
| Jun 10, 2026 | Winston Kung Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,026 | $7.91 | $16.0K Sale | Form 4 ↗ |
| Jun 10, 2026 | John Kenneth Jenkins Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 4,800 | $7.91 | $38.0K Sale | Form 4 ↗ |
| Jun 10, 2026 | Anne Altmeyer Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,412 | $7.91 | $19.1K Sale | Form 4 ↗ |
| Jun 3, 2026 | Nishant C. Saxena Chief Business Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Buy | 9,000 | $7.58 | $68.2K Buy | Form 4 ↗ |
| Jun 2, 2026 | Nishant C. Saxena Chief Business Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Buy | 4,500 | $7.33 | $33.0K Buy | Form 4 ↗ |
| Mar 2, 2026 | Dominic Smethurst Chief Medical Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 6,097 | $8.30 | $50.6K Sale | Form 4 ↗ |
| Feb 17, 2026 | Ian Hodgson Chief Operating Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 847 | $7.38 | $6,251 Sale | Form 4 ↗ |
| Feb 13, 2026 | Sean F. Moran Chief Financial Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 4,701 | $7.78 | $36.6K Sale | Form 4 ↗ |
| Feb 13, 2026 | Yuval Cohen Chief Executive Officer, Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 13,871 | $7.78 | $107.9K Sale | Form 4 ↗ |
| Feb 3, 2026 | Dominic Smethurst Chief Medical Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 3,285 | $8.09 | $26.6K Sale | Form 4 ↗ |
| Feb 3, 2026 | Ian Hodgson Chief Operating Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,415 | $8.09 | $19.5K Sale | Form 4 ↗ |
| Dec 11, 2025 | Bihua Chen 10% owner | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 30,029 | $11.46 | $344.1K Sale | Form 4 ↗ |
| Oct 27, 2025 | Yuval Cohen Chief Executive Officer, Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 8,973 | $17.14 | $153.8K Sale | Form 4 ↗ |
| Oct 24, 2025 | Yuval Cohen Chief Executive Officer, Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 18,660 | $17.01 | $317.4K Sale | Form 4 ↗ |
| Oct 24, 2025 | Sean F. Moran Chief Financial Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 12,981 | $17.02 | $220.9K Sale | Form 4 ↗ |
| Oct 20, 2025 | Anne Altmeyer Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 1,060 | $20.50 | $21.7K Sale | Form 4 ↗ |
| May 30, 2025 | John Kenneth Jenkins Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,783 | $7.35 | $20.5K Sale | Form 4 ↗ |
| May 30, 2025 | Anne Altmeyer Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 1,392 | $7.25 | $10.1K Sale | Form 4 ↗ |
| Mar 6, 2025 | Dominic Smethurst Chief Medical Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 6,393 | $6.78 | $43.3K Sale | Form 4 ↗ |
| Feb 14, 2025 | Sean F. Moran Chief Financial Officer | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 2,792 | $8.76 | $24.5K Sale | Form 4 ↗ |
| Feb 14, 2025 | Yuval Cohen Chief Executive Officer, Director | CRBP Corbus Pharmaceuticals Holdings, Inc. | Sale | 7,134 | $8.76 | $62.5K Sale | Form 4 ↗ |
26 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 7:18 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances